Venker Eric 4
4 · Roivant Sciences Ltd. · Filed Nov 24, 2025
Insider Transaction Report
Form 4
Venker Eric
President & Immunovant CEO
Transactions
- Tax Payment
Common Shares
2025-11-20$20.27/sh−7,051$142,924→ 1,497,908 total
Footnotes (1)
- [F1]Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.